Research
Hormonal
GLP-1 medicines reduce food intake, body weight, insulin resistance and inflammation.
GLP-1 medicines can be considered for managing weight and metabolic health in patients with type 2 diabetes and obesity.
StrongSupportsmedium confidence
Glucagon-like peptide-1 (GLP-1) medicines reduce food intake, body weight, insulin resistance and inflammation.
Why this rating
The claim is based on data summarized from trials and registries.
Source
Glucagon-like peptide-1 medicines and cancer
Julian M. Yabut et al. · Nature Cancer · 2026
otherCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →